Theravance Biopharma (TBPH) Price Target Increased by 10.00% to 15.71

6d ago, source: Fintel on MSN

The average one-year price target for Theravance Biopharma (NasdaqGM:TBPH) has been revised to 15.71 / share. This is an ...

TBPH Theravance Biopharma, Inc.

7d ago, source: Seeking Alpha

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized ...

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?

8d ago, source:

Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Theravance Biopharma, Inc. (0TB.F)

19d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Theravance Biopharma, Inc. (TBPH)

7d ago, source: Yahoo Finance

Theravance Biopharma, Inc. (the "Company") (NASDAQ: TBPH) today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio Kaufmann ...

Theravance Biopharma Inc TBPH

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Theravance Biopharma Inc.

26d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...